An article about our company appeared in Japan Chemical Daily
NATiAS (Chuo-ku, Kobe), a CDMO (Contract Development and Manufacturing Organization) for oligonucleotide APIs in which Mitsui Chemicals, Toray Engineering, and other companies have invested, is developing a large-scale CDMO using a proprietary manufacturing method that is suitable for mass production and the company will begin to aim new projects…read more
Announcement of capital and business alliance with Mitsui Chemicals, Inc.
NATiAS Inc. (Head office: Chuo-ku, Kobe; CEO: Masanori Kataoka) is pleased to announce that NATiAS has agreed to a third-party allotment of new shares with Mitsui Chemicals, Inc. (Head office: Minato-ku, Tokyo; President & CEO: Osamu Hashimoto) forming a business alliance…read more